7 completed, 1 unknown. 2 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 4 | 1 | Completed 1 |
Follow Anemia, Macrocytic: new trials by email Literature Review of Anemia, Macrocytic trials Research Report on Anemia, Macrocytic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Acceptability and Nutritional Impact of Double-fortified Salt Containing Iodine and Folic Acid Iodized salt, Experimental: Iodized salt with lower-dose folic acid fortification, Experimental: Iodized salt with higher-dose folic acid fortification - Folate Deficiency, Iodine Deficiency | Not applicable | Completed | University of California, Davis | 360 | 2024-04-25 | 2025-03-13 |
| Effectiveness of Fortification With Folic Acid and Vitamin B12 Among Teenage Girls Folic acid and vitamin B12 fortified flour, Unfortified cereal flour - Folate Deficiency, Vitamin B 12 Deficiency | Not applicable | Completed | University Ghent | 472 | 2023-12-11 | 2026-08-14 |
| Acceptability and Nutritional Impact of Double-fortified Salt Containing Iodine and Folic Acid - Phase 1 Folate Deficiency, Iodine Deficiency | Completed | University of California, Davis | 100 | 2023-06-26 | 2025-03-13 | |
| Pyloric or Pseudopyloric Metaplasia of the Corpus Mucosa in Autoimmune Gastritis Assess pyloric or pseudopyloric metaplasia of corpus by H&E stains, Assess pyloric or pseudopyloric metaplasia of corpus by TFF2 immunohistochemistry stains, The assessment of corpus-predominant gastritis index (CGI), Operative Link for Gastritis Assessment (OLGA), and Operative Link on Gastric Intestinal Metaplasia assessment (OLGIM) - Autoimmune Diseases, Helicobacter Pylori Gastritis | Unknown | National Cheng-Kung University Hospital | 300 | 2022-01-01 | 2023-10-03 | |
| The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic Exposure of interest - Alopecia Areata, Alopecia Totalis | Completed | Faculty Hospital Kralovske Vinohrady | 123 | 2021-10-15 | 2024-12-03 | |
| The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata Exposure of interest (studies 2 & 3). - Alopecia Areata, Depressive Episode | Completed | Momentum Data | 51955 | 2020-10-01 | 2022-12-15 | |
| Megadose of Hydroxocobalamin for the Treatment of Pernicious Anemia Hydroxocobalamin 10,000mcg, Thiamin 100mg, Pyridoxine 50mg - Megaloblastic Anemia Nos, Pernicious Anemia | Phase 4 | Completed | Hospital Universitario Dr. Jose E. Gonzalez | 13 | 2017-12-27 | 2021-03-08 |
| Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity SCAD, Addison Disease | Completed | Mayo Clinic | 114 | 1995-01-01 | 2020-11-23 |
Anemia, Pernicious (5) · Arthritis, Rheumatoid (3) · Autoimmune Diseases (3) · Colitis, Ulcerative (3) · Crohn Disease (3) · Diabetes Mellitus, Type 1 (3) · Folic Acid Deficiency (3) · Graves Disease (3) · Multiple Sclerosis (3) · Psoriasis (3) · Spondylitis, Ankylosing (3) · Vitiligo (3) · Alopecia Areata (2) · Anemia, Megaloblastic (2)
Avitaminosis (8) · Deficiency Diseases (8) · Hematologic Diseases (8) · Hemic and Lymphatic Diseases (8) · Malnutrition (8) · Nutrition Disorders (8) · Nutritional and Metabolic Diseases (8) · Vitamin B Deficiency (8) · Anemia (7) · Vitamin B 12 Deficiency (5) · Anemia, Megaloblastic (4) · Digestive System Diseases (4) · Gastroenteritis (4) · Gastrointestinal Diseases (4)
Control Groups (1) · Folic Acid (1) · Hydroxocobalamin (1) · Pyridoxine (1) · Thiamine (1) · iodized salt (1)
University of California, Davis (2) · Faculty Hospital Kralovske Vinohrady (1) · Hospital Universitario Dr. Jose E. Gonzalez (1) · Mayo Clinic (1) · Momentum Data (1) · National Cheng-Kung University Hospital (1) · University Ghent (1)
Ethiopia (3) · Czechia (1) · Mexico (1) · Taiwan (1) · United Kingdom (1) · United States (1)
Andrew McGovern, MD (1) · Hsiu-Chi Cheng, MD, PhD (1) · Kenneth H Brown, MD (1) · Masresha Tessema, PhD (1) · Stefaan De Henauw, MD,PHD (1)
PMID 14616423, PMID 22650964, PMID 23550594, PMID 23697526, PMID 28326664, PMID 28360040, PMID 33515301, PMID 34785540, PMID 35157313, PMID 39673143, PMID 41611087, PMID 42253364, PMID 42400612, PMID 42437195